N-heterocyclic aromatics are environmentally important pollutants, however, little is known of their mechanism of action or biological effects. The objective is to investigate the metabolic activation of 7H-dibenz(c,g)carbazole (DBC) which is a potent carcinogen in mouse lung, liver, and skin, with respect to dibenz(a,j)acridine (DBA) a moderate to weak carcinogen in mouse lung and skin. Since the structural difference between the well characterized polycyclic aromatic hydrocarbons and the N-heterocyclic analogs is the existence of a nitrogen atom in the aromatic ring system of the latter, it is hypothesized that any differences in metabolism, metabolic activation, DNA binding, or carcinogenic potency is due not only to the presence of a nitrogen atom but to the aromaticity of the heteroatom containing ring.
The specific aims i nvolve the characterization of the metabolic activation and DNA binding of DBC and DBA in mouse skin and liver as follows: 1) determine the modulation of metabolism of DBC and DBA incubated with liver preparations using a variety of inducing agents, 2) determine the modulation of DNA binding of DBC and DBA with induced liver preparations, 3) determine the modulation of metabolism of DBC and DBA with induced skin preparations, 4) characterize the covalent binding of selected metabolites of DBC and DBA to DNA in vitro with liver preparations, 5) characterize the covalent binding of DBC and DBA to DNA in skin and liver in vivo and 6) undertake chronic dose response carcinogenicity studies for DBC and DBA relative to benzo(a)pyrene and mixtures thereof. Phenobarbital, Aroclor 1254, DBC, DBA and 3-methylcholanthrene will be used for enzyme induction and subcellular liver and skin fractions will be prepared. Metabolism of DBC and DBA will be analyzed by HPLC and alumina column chromatography. In vitro DNA binding and DNA adducts (as standards) will be analyzed by radiometry, HPLC, and analytical techniques. In vivo studies will involve the development of finger prints of DNA adducts using (32)P-postlabeling techniques and dephosphorylation of the adducts for comparison with in vitro adducts. Lastly, analysis of the biological responses of mixtures will determine whether additive, synergistic or inhibitory effects are involved. This approach will provide valuable information concerning the disposition of an important class of carcinogens and will lead to a better understanding of the mechanism(s) of action of N-heterocyclic aromatic carcinogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES004203-06
Application #
3252215
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1987-08-01
Project End
1994-07-31
Budget Start
1992-08-01
Budget End
1994-07-31
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Cincinnati
Department
Type
Schools of Medicine
DUNS #
City
Cincinnati
State
OH
Country
United States
Zip Code
45221
Talaska, Glenn; Ginsburg, David; LaDow, Kathy et al. (2006) Impact of Cyp1a2 or Ahr gene knockout in mice: implications for biomonitoring studies. Toxicol Lett 162:246-9
Xue, Weiling; Warshawsky, David (2005) Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: a review. Toxicol Appl Pharmacol 206:73-93
O'Brien, T; Schneider, J; Warshawsky, D et al. (2002) In vitro toxicity of 7H-dibenzo[c,g]carbazole in human liver cell lines. Toxicol In Vitro 16:235-43
Xue, Weiling; Siner, Angela; Rance, Mark et al. (2002) A metabolic activation mechanism of 7H-dibenzo[c,g]carbazole via o-quinone. Part 2: covalent adducts of 7H-dibenzo[c,g]carbazole-3,4-dione with nucleic acid bases and nucleosides. Chem Res Toxicol 15:915-21
Gray, D L; Warshawsky, D; Xue, W et al. (2001) The effects of a binary mixture of benzo(a)pyrene and 7H-dibenzo(c,g)carbazole on lung tumors and K-ras oncogene mutations in strain A/J mice. Exp Lung Res 27:245-53
Mitchell, K R; Warshawsky, D (2001) Comparison of Ha-ras mutational spectra of N-methyldibenzo[c,g]carbazole and 7H-dibenzo[c,g]carbazole-induced mouse skin tumors. Mol Carcinog 32:55-60
Xue, W; Schneider, J; Mitchell, K et al. (2001) trans-3,4-dihydroxy-anti-1,2-epoxy-1,2,3,4-tetrahydrodi- benz[a,j]acridine involvement in dibenz[a,j]acridine DNA adduct formation in mouse skin consistent with Ha-ras mutation patterns in tumors. Chem Res Toxicol 14:871-8
Dowty, H V; Xue, W; LaDow, K et al. (2000) One-electron oxidation is not a major route of metabolic activation and DNA binding for the carcinogen 7H-dibenzo[c,g]carbazole in vitro and in mouse liver and lung. Carcinogenesis 21:991-8
O'Brien, T; Babcock, G; Cornelius, J et al. (2000) A comparison of apoptosis and necrosis induced by hepatotoxins in HepG2 cells. Toxicol Appl Pharmacol 164:280-90
Mitchell, K R; Warshawsky, D (1999) Frequent Ha-ras mutations in murine skin and liver tumors induced by 7H-dibenzo[c,g]carbazole. Mol Carcinog 25:107-12

Showing the most recent 10 out of 27 publications